PL340555A1 - Preparations containing dissolved paroxetin - Google Patents

Preparations containing dissolved paroxetin

Info

Publication number
PL340555A1
PL340555A1 PL98340555A PL34055598A PL340555A1 PL 340555 A1 PL340555 A1 PL 340555A1 PL 98340555 A PL98340555 A PL 98340555A PL 34055598 A PL34055598 A PL 34055598A PL 340555 A1 PL340555 A1 PL 340555A1
Authority
PL
Poland
Prior art keywords
paroxetin
preparations containing
containing dissolved
dissolved
preparations
Prior art date
Application number
PL98340555A
Other languages
English (en)
Inventor
Ahmad Ghazawi
Graham Stanley Leonard
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of PL340555A1 publication Critical patent/PL340555A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL98340555A 1997-11-21 1998-11-18 Preparations containing dissolved paroxetin PL340555A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9724544.3A GB9724544D0 (en) 1997-11-21 1997-11-21 Novel Formulation
PCT/GB1998/003471 WO1999026625A1 (en) 1997-11-21 1998-11-18 Formulations comprising dissolved paroxetine

Publications (1)

Publication Number Publication Date
PL340555A1 true PL340555A1 (en) 2001-02-12

Family

ID=10822374

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98340555A PL340555A1 (en) 1997-11-21 1998-11-18 Preparations containing dissolved paroxetin

Country Status (24)

Country Link
EP (1) EP1033986A1 (no)
JP (1) JP2001523718A (no)
KR (1) KR20010032320A (no)
CN (1) CN1279608A (no)
AP (1) AP2000001821A0 (no)
AR (1) AR015485A1 (no)
AU (1) AU1168099A (no)
BG (1) BG104527A (no)
BR (1) BR9814220A (no)
CO (1) CO4970832A1 (no)
DZ (1) DZ2658A1 (no)
EA (1) EA200000552A1 (no)
GB (1) GB9724544D0 (no)
HU (1) HUP0100580A3 (no)
IL (1) IL136106A0 (no)
MA (1) MA24704A1 (no)
NO (1) NO20002590L (no)
OA (1) OA11385A (no)
PE (1) PE20000381A1 (no)
PL (1) PL340555A1 (no)
SK (1) SK7342000A3 (no)
TR (1) TR200001423T2 (no)
WO (1) WO1999026625A1 (no)
ZA (1) ZA9810637B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810180D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulation
EP1161241B1 (de) * 1999-03-12 2005-12-07 Aesica Pharmaceuticals Ltd. Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
ATE248165T1 (de) 1999-07-01 2003-09-15 Italfarmaco Spa Komplexe von paroxetin mit cyclodextrin oder cyclodextrin derivaten
DE19930454A1 (de) * 1999-07-02 2001-01-04 Knoll Ag Feste Paroxetin enthaltende Zubereitungen
US6720003B2 (en) 2001-02-16 2004-04-13 Andrx Corporation Serotonin reuptake inhibitor formulations
DE60222803T2 (de) * 2001-12-21 2008-07-17 Supernus Pharmaceuticals, Inc. Orale kapselformulierung mit verbesserter physikalischer stabilität
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
WO2006119779A2 (en) * 2005-05-10 2006-11-16 Lifecycle Pharma A/S A pharmaceutical composition comprising an aldosterone antagonist in form of solid solution
WO2011071194A1 (ko) * 2009-12-08 2011-06-16 주식회사 일화 20-O-β-D-글루코피라노실-20(S)-프로토파낙사디올을 포함하는 고체분산체
GB201020032D0 (en) * 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2216934A1 (en) * 1995-04-03 1996-10-10 Abbott Laboratories Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
KR20000070151A (ko) * 1997-01-15 2000-11-25 피터 기딩스 파록세틴 조성물

Also Published As

Publication number Publication date
DZ2658A1 (fr) 2003-03-22
BG104527A (en) 2001-04-30
HUP0100580A3 (en) 2002-05-28
EP1033986A1 (en) 2000-09-13
ZA9810637B (en) 2000-05-22
CN1279608A (zh) 2001-01-10
WO1999026625A1 (en) 1999-06-03
KR20010032320A (ko) 2001-04-16
AR015485A1 (es) 2001-05-02
TR200001423T2 (tr) 2000-10-23
NO20002590L (no) 2000-07-19
EA200000552A1 (ru) 2000-10-30
IL136106A0 (en) 2001-05-20
AP2000001821A0 (en) 2000-06-30
MA24704A1 (fr) 1999-07-01
CO4970832A1 (es) 2000-11-07
SK7342000A3 (en) 2000-12-11
JP2001523718A (ja) 2001-11-27
NO20002590D0 (no) 2000-05-19
AU1168099A (en) 1999-06-15
BR9814220A (pt) 2001-12-26
HUP0100580A2 (hu) 2002-04-29
GB9724544D0 (en) 1998-01-21
OA11385A (en) 2004-01-27
PE20000381A1 (es) 2000-05-07

Similar Documents

Publication Publication Date Title
GB2368979B (en) Adapters
GB2325840B (en) Heater-sensor complex
PL340075A1 (en) Strongly basic preparations containing hexylglyciside as a hydrothrope
PL337324A1 (en) Stable insulin preparations
PL334976A1 (en) Pharmaceutic preparations containing amoxycyclin and clavulate
ZA989538B (en) Single mould-half alignment
GB9715751D0 (en) Formulations
GB9825535D0 (en) Pyrometer-multimeter
HUP0002127A3 (en) Syringe
EP0979660A4 (en) SYRINGE
EP1074251A4 (en) ADHESIVE PREPARATIONS
SG76535A1 (en) Pharmaceutical agents
PL341604A1 (en) Local application ophthalmic preparations containing immunossuppressive agents
AU3089199A (en) Preparations containing licariin
PL340555A1 (en) Preparations containing dissolved paroxetin
GB9700789D0 (en) Syringe
EP1004309A4 (en) AQUEOUS PREPARATIONS CONTAINING ISRAPAFANT
GB9717883D0 (en) Vial
HUP0003038A3 (en) Low dosed 15-desoxyspergualine preparations
GB9813448D0 (en) Barrier preparations
GB9703676D0 (en) Stable system
IL136525A0 (en) Agents
HUP9903097A3 (en) Medicament containing progestogen-anti-progestogen
CA82556S (en) Capsule
GB9701325D0 (en) Sequence